NEW YORK (GenomeWeb) — Foundation Medicine said today that the company has been added to the Nasdaq Biotechnology Index. 

The index tracks Nasdaq-listed securities that are classified as either biotechnology or pharmaceutical by the Industry Classification Benchmark. The index, which is reranked each year, is also the basis for the iShares Nasdaq Biotechnology Index Fund. The fund seeks investment results corresponding generally to the price and yield performance of the Nasdaq Biotechnology Index, and options based on the index fund trade on various exchanges. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.